British American Tobacco (BATS) Gets a Hold from Goldman Sachs
In a report released today, Richard Felton from Goldman Sachs maintained a Hold rating on British American Tobacco, with a price target of £45.50.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Felton is a 3-star analyst with an average return of 4.8% and a 55.08% success rate. Felton covers the Healthcare sector, focusing on stocks such as GN Store Nord, Demant, and EssilorLuxottica SA.
In addition to Goldman Sachs, British American Tobacco also received a Hold from TipRanks – xAI’s xAi Consumer Defensive GB in a report issued on February 18. However, on February 19, Barclays maintained a Buy rating on British American Tobacco (LSE: BATS).
Based on British American Tobacco’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p13.54 billion and a net profit of p3.25 billion. In comparison, last year the company earned a revenue of p13.53 billion and had a GAAP net loss of p1.45 billion
Based on the recent corporate insider activity of 99 insiders, corporate insider sentiment is neutral on the stock.
Read More on GB:BATS:
Disclaimer & DisclosureReport an Issue
- British American Tobacco Cancels Newly Repurchased Shares Under Buyback Programme
- British American Tobacco Cancels New Tranche of Repurchased Shares
- Organigram announces C$65.2M BAT private placement investment
- BAT Reaffirms 2026 Outlook as It Leans Further Into Smokeless Products
- British American Tobacco Cancels 111,000 Shares After Latest Buyback
